EA
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021) : a longitudinal study in Switzerland | International journal for equity in health |  | 2023 | 126 | 125 | ||
| Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe | Alzheimer's & dementia | | 2022 | 353 | 307 | ||
| The strategic biomarker roadmap for the validation of Alzheimer's diagnostic biomarkers: methodological update | European Journal of Nuclear Medicine and Molecular Imaging | | 2021 | 355 | 221 | ||
| Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland | International Journal of Public Health | | 2020 | 300 | 119 | ||
| Returning individual-specific results of a dementia prevalence study: insights from prospective participants living in Switzerland | International Journal of Geriatric Psychiatry |  | 2020 | 370 | 0 | ||
| Mortality in people with mental disorders in the Czech Republic: a nationwide, register-based cohort study | The Lancet Public Health | | 2018 | 1,005 | 190 | ||
| The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues | Neurobiology of aging | | 2017 | 515 | 7 | ||
| Body mass index in midlife and dementia: Systematic review and meta-regression analysis of 589,649 men and women followed in longitudinal studies | Alzheimer's & Dementia | | 2017 | 574 | 342 | ||
| The biomarker-based diagnosis of Alzheimer's disease. 2-lessons from oncology | Neurobiology of Aging | | 2017 | 516 | 2 | ||
| Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers | The Lancet Neurology | | 2017 | 691 | 7 | ||
| Discussion of the updated WHO recommendations for mental, neurological, and substance use disorders | The Lancet. Psychiatry | | 2016 | 728 | 0 |
